Concepedia

Edvardas Kaminskas

EK

Statistics

Publications

29

Citations

2.4K

H-Index

21

Active since

1960

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Beth Israel Deaconess Hospital

Harvard University

Mount Sinai Medical Center

Edvardas Kaminskas is an author at Center for Drug Evaluation and Research specializing in medicine, cell biology, and biochemistry.

Top concepts

Publications per year

1960–2018

29

Publications

29

Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

Edvardas Kaminskas, Ann Farrell, Sophia Abraham et al. · Clinical Cancer Research · 2005 · 417 citations

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas et al. · Clinical Cancer Research · 2013 · 240 citations

, , +15

Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

Michael H. Brave, Vicki Goodman, Edvardas Kaminskas et al. · Clinical Cancer Research · 2008 · 239 citations

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro, Karen M. McGinn, Virginia E. Kwitkowski et al. · Clinical Cancer Research · 2012 · 207 citations

, , +12

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

R. Angelo de Claro, Karen M. McGinn, Nicole Verdun et al. · Clinical Cancer Research · 2015 · 156 citations

, , +18

1–5 of 29